NCT02490670View on ClinicalTrials.gov

A Study of Cephalexin Liquid in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Healthy
Interventions
DRUG

Cephalexin

Administered orally

Trial Locations (1)

14610

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Mexico City

All Listed Sponsors
collaborator

Investigacion Farmacologica y Biofarmaceutica, S.A. de C.V.

OTHER

lead

Eli Lilly and Company

INDUSTRY

NCT02490670 - A Study of Cephalexin Liquid in Healthy Participants | Biotech Hunter | Biotech Hunter